Outcome of Surgery for Idiopathic Macular Holes

Idiopathic Macular Hole Clinical Trial

— TROMAC  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02895594
• Other study ID #: NI_YLR_2015_1
• Status: Completed
• Phase: N/A
• First received: September 6, 2016
• Last updated: September 9, 2016
• Start date: January 2012

Study information

• Verified date: September 2016
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: The Commission nationale de l’informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Retrospective medical chart review of patients undergoing surgical repair of idiopathic macular hole

Recruitment information / eligibility

• Status: Completed
• Enrollment: 59
• Est. primary completion date: May 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient suffering from primary idiopathic macular hole and treated by retinal repair surgery

Exclusion Criteria:

• Presence of other retinal disease

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Idiopathic Macular Hole
• Retinal Perforations

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Primary closure of macular hole after repair surgery		within six months after surgery	No